How customers perceive Oracle Cerner

Large health systems are more likely to say they don’t have an optimistic view of Oracle Cerner, with reasons including delays in its revenue cycle product and staffing issues, a March 21 KLAS Research report found.

Advertisement

KLAS surveyed more than 20 Oracle Cerner customers throughout 2022, when Oracle took over ownership of Cerner. In November, about a fourth reported that they no longer saw the EHR vendor as a viable long-term partner, with health systems of 1,000 or more beds being more likely to switch opinions.

Here are the top concerns the 24 organizations had about Oracle Health in that November survey:

1. Road map: 75 percent.

2. Execution/delivery: 42 percent.

3. Vendor’s staffing availability: 29 percent.

4. Cost/value: 25 percent.

Not yet delivering on the promise of the RevElate revenue cycle product and the company’s layoffs were often cited, the report found. Oracle Cerner didn’t respond to a request from Becker’s for comment.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.